focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 331.00
Bid: 329.50
Ask: 330.00
Change: 7.50 (2.32%)
Spread: 0.50 (0.152%)
Open: 318.00
High: 331.00
Low: 318.00
Prev. Close: 323.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EnSilica hires new chief financial officer from Oxford Biomedica

Mon, 05th Feb 2024 11:34

(Alliance News) - EnSilica PLC on Monday said it has appointed a new chief financial officer, who will join the company and board in May.

The Abingdon, Oxfordshire-based semiconductor designer and supplier said Kristoff Rademan will join from Oxford Biomedica PLC, where he currently serves as financial controller.

Rademan has over 20 years of experience working in corporate finance positions across the pharmaceutical and technology sectors, EnSilica said, including a "diverse" range of senior finance management roles.

In April last year, Matthew Wethey stepped down as CFO, replaced by Chris Mann on an interim basis.

"I am delighted to welcome Kristoff to EnSilica and look forward to leveraging his vast experience in executive finance roles at innovation-led companies. Kristoff will provide extensive financial support to EnSilica, and I and the board look forward to working with him as we continue to focus on executing our growth strategy," said Chief Executive Officer Ian Lankshear.

Shares in EnSilica were down 2.2% to 46.46 pence each in London on Monday morning.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
27 Jul 2020 08:13

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

Read more
15 Jul 2020 11:42

AstraZeneca Covid-19 vaccine shows promise - report

(Sharecast News) - A Covid-19 vaccine backed by AstraZeneca is producing positive results in initial trials, according to a report.

Read more
2 Jul 2020 17:54

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

Read more
24 Jun 2020 15:21

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

Read more
19 Jun 2020 14:40

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

Read more
18 Jun 2020 18:26

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Read more
8 Jun 2020 17:12

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Read more
8 Jun 2020 11:54

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

Read more
8 Jun 2020 09:41

UPDATE 2-UK stocks end lower on concerns over corporate debt; AstraZeneca weighs

* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain after OPEC production cuts* BP rises after report of job cuts (Adds details, updates to close)By Shr...

Read more
3 Jun 2020 17:28

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

Read more
1 Jun 2020 12:02

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

Read more
1 Jun 2020 07:43

UPDATE 2-AstraZeneca scores twin drug approvals alongside vaccine progress

* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxford Biomedica appoints new chair (Writes through, adds detail, context)June 1 (Reuters) - Britain's...

Read more
28 May 2020 12:41

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Read more
14 May 2020 09:19

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

Read more
6 May 2020 15:07

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.